26.11.2012 Views

Peptide-Based Drug Design

Peptide-Based Drug Design

Peptide-Based Drug Design

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

74 Giannakis et al.<br />

surface to analyze membrane binding proteins. Proteins retained on the chip<br />

surface are resolved via TOF-MS, which displays the mass-to-charge value and<br />

signal intensities of the proteins (20).<br />

ProteinChip arrays with preactivated surfaces are also available for covalently<br />

coupling of a specific “bait” molecule (protein, DNA, RNA). This allows the<br />

investigation of specific protein interactions such as DNA–protein, receptor–<br />

ligand, and antibody-antigen (Ab-Ag), the latter of which permits the generation<br />

of a standard curve and hence quantitation studies (21).<br />

1.3. Quantitation of Aβ<br />

Traditional methods employed to examine A� processing include enzyme<br />

linked immunosorbant assays (ELISA) and SDS-PAGE/Western blotting.<br />

ELISA generates an average signal of all peptide species bound to the<br />

antibody Ab and hence has poor assay specificity. Analysis of A� by SDS-<br />

PAGE/Western blotting exhibits poor discriminatory power between the variant<br />

forms of the peptide. In addition, molecular weights of peptides cannot be<br />

accurately determined. Hence, using these techniques for the analysis of multiple<br />

A� species can be difficult.<br />

In contrast, ProteinChip technology allows the detailed analysis of A�<br />

fragments and their modifications (22). <strong>Peptide</strong>s are captured on arrays coated<br />

with anti-A� Ab, washed to remove nonspecifically bound fragments, and finally<br />

detected by SELDI-TOF MS. The resolution of the technique allows the discrimination<br />

of peptides of similar mass and modified products, e.g., oxidized peptides<br />

versus native peptides, which differ by only 16 Da. ProteinChip technology has<br />

been used extensively to detect A� fragments in various samples, including cell<br />

culture supernatants, serum, plasma, and cerebrospinal fluid (CSF) (21–23).<br />

1.4. Aβ Aggregation and Interactions with Lipids<br />

Analysis of A� aggregation typically involves performing circular dichoism<br />

(CD) spectroscopy, thioflavin T assays, electron microscopy, SDS-PAGE,<br />

and chromatography. These techniques describe the aggregation of A� in a<br />

general sense without the ability to accurately quantitate the generation of<br />

specific oligomeric species. Photo-induced cross-linking of unmodified proteins<br />

(PICUP) assays have also been used for assessing oligomeric profiles. This<br />

method employs photolysis to induce covalent bonds between transiently<br />

formed oligomers. The PICUP method, however, is prone to artifacts by crosslinking<br />

transitory interactions. In addition, PICUP oligomers are assessed via<br />

SDS-PAGE/Western blotting, the limitations of which have been previously<br />

described. In contrast, SELDI-TOF MS can be used to generate oligomeric<br />

profiles and assess relative changes in stable oligomeric species.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!